Biomedecine SRL
Biomedecine reported total assets of 27,357 € at the end of the 2025 financial year (annual accounts filed with the NBB on 23 Jul 2026).
The score of Biomedecine shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -36 % Total assets -54 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Biomedecine's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Jul 2026
- Year ended 31 Dec 2024filed on 27 Jun 2025
- Year ended 31 Dec 2023filed on 19 Jun 2024
- Year ended 31 Dec 2022filed on 20 Jul 2023
- Year ended 31 Dec 2021filed on 28 Jul 2022
Biomedecine's financial analysis
- Solvency52.9%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Biomedecine
Biomedecine's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0426.653.609
- VAT number
- BE0426653609
- Peppol
- Registered · 0208:0426653609 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 09 Jan 1985
- Registered office
- 1800 Vilvoorde
- Latest accounts
- 2025 · filed on 23 Jul 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Biomedecine (SRL) has been based in Vilvoorde since 1985, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net loss of 8,581 € and equity of 14,468 €; its revenue is not published. Its solvency stands at 52.9%, above the median of its sector (46.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Biomedecine
Companies in the same business, of comparable size and area, outside its group.
- AlphaCare Wholesale of pharmaceutical and medical goods Grez-Doiceau · balance sheet 559,557 €
- Linden API Wholesale of pharmaceutical and medical goods Ixelles · balance sheet 12,520 €
- Borloo Wholesale of pharmaceutical and medical goods Kortenberg · balance sheet 253,406 €
- Cirba Wholesale of pharmaceutical and medical goods Ixelles · balance sheet 67,062 €
- Smartvalue Distribution Wholesale of pharmaceutical and medical goods Liège · balance sheet 56,516 €
- Dental Budget Wholesale of pharmaceutical and medical goods Ghent · balance sheet 69,929 €
- BVH Consulting Wholesale of pharmaceutical and medical goods Floreffe · balance sheet 44,707 €
- Prothéses d'Oreille Utilitaires dans la Recherche et la Technologie Wholesale of pharmaceutical and medical goods Manage · balance sheet 17,598 €
Frequently asked questions about Biomedecine
What is the revenue of Biomedecine?
Biomedecine files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Biomedecine?
In Belgium, the VAT number is the company number prefixed with BE: BE0426653609 for Biomedecine, if the company is VAT-registered. Its company number (CBE) is 0426.653.609.
Where is the registered office of Biomedecine?
According to the CBE register, the registered office of Biomedecine is in 1800 Vilvoorde.
What is the equity of Biomedecine?
At the close of the 2025 financial year, the equity of Biomedecine amounts to 14,468 €, a solvency of 52.9% of total assets.
Who manages Biomedecine?
The register lists 1 active mandates at Biomedecine. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Biomedecine
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →